HSV-1-based Vectors for Gene Therapy of Neurological Diseases and Brain Tumors: Part I. HSV-1 Structure, Replication and Pathogenesis

Overview

Journal Neoplasia

Publisher Elsevier

Specialty Oncology

Date 2000 Aug 10

PMID 10933054

Citations 10

Authors

A Jacobs

X O Breakefield

C Fraefel

Affiliations

Soon will be listed here.

Abstract

The design of effective gene therapy strategies for brain tumors and other neurological disorders relies on the understanding of genetic and pathophysiological alterations associated with the disease, on the biological characteristics of the target tissue, and on the development of safe vectors and expression systems to achieve efficient, targeted and regulated, therapeutic gene expression. The herpes simplex virus type 1 (HSV-1) virion is one of the most efficient of all current gene transfer vehicles with regard to nuclear gene delivery in central nervous system-derived cells including brain tumors. HSV-1-related research over the past decades has provided excellent insight into the structure and function of this virus, which, in turn, facilitated the design of innovative vector systems. Here, we review aspects of HSV-1 structure, replication and pathogenesis, which are relevant for the engineering of HSV-1-based vectors.

Citing Articles

Antiviral Bioactive Compounds of Mushrooms and Their Antiviral Mechanisms: A Review.

Seo D, Choi C Viruses. 2021; 13(2).

PMID: 33672228 PMC: 7926341. DOI: 10.3390/v13020350.

Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy.

Nguyen H, Guz-Montgomery K, Saha D Cells. 2020; 9(2).

PMID: 32050597 PMC: 7072539. DOI: 10.3390/cells9020400.

Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review.

Shafi O BMC Neurol. 2016; 16(1):236.

PMID: 27875990 PMC: 5120447. DOI: 10.1186/s12883-016-0765-2.

Glioblastoma multiforme: State of the art and future therapeutics.

Wilson T, Karajannis M, Harter D Surg Neurol Int. 2014; 5:64.

PMID: 24991467 PMC: 4078454. DOI: 10.4103/2152-7806.132138.

Herpes simplex virus-based nerve targeting gene therapy in pain management.

Goss J, Krisky D, Wechuck J, Wolfe D J Pain Res. 2014; 7:71-9.

PMID: 24470772 PMC: 3901742. DOI: 10.2147/JPR.S36619.

References

Baringer J, Swoveland P . Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med. 1973; 288(13):648-50. DOI: 10.1056/NEJM197303292881303. View

Cook M, Stevens J . Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect Immun. 1973; 7(2):272-88. PMC: 422671. DOI: 10.1128/iai.7.2.272-288.1973. View

Honess R, Roizman B . Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol. 1974; 14(1):8-19. PMC: 355471. DOI: 10.1128/JVI.14.1.8-19.1974. View

Heine J, Honess R, Cassai E, Roizman B . Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains. J Virol. 1974; 14(3):640-51. PMC: 355559. DOI: 10.1128/JVI.14.3.640-651.1974. View

Jamieson A, Gentry G . Induction of both thymidine and deoxycytidine kinase activity by herpes viruses. J Gen Virol. 1974; 24(3):465-80. DOI: 10.1099/0022-1317-24-3-465. View

Jamieson A . Biochemical studies on the herpes simplex virus-specified deoxypyrimidine kinase activity. J Gen Virol. 1974; 24(3):481-92. DOI: 10.1099/0022-1317-24-3-481. View

Schaeffer H, Beauchamp L, de Miranda P, ELION G, Bauer D, Collins P . 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature. 1978; 272(5654):583-5. DOI: 10.1038/272583a0. View

Jacob R, Morse L, Roizman B . Anatomy of herpes simplex virus DNA. XII. Accumulation of head-to-tail concatemers in nuclei of infected cells and their role in the generation of the four isomeric arrangements of viral DNA. J Virol. 1979; 29(2):448-57. PMC: 353176. DOI: 10.1128/JVI.29.2.448-457.1979. View

Baucke R, Spear P . Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J Virol. 1979; 32(3):779-89. PMC: 525925. DOI: 10.1128/JVI.32.3.779-789.1979. View

10.

Cohen G, Ponce de Leon M, DIGGELMANN H, LAWRENCE W, Vernon S, Eisenberg R . Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2. J Virol. 1980; 34(2):521-31. PMC: 288732. DOI: 10.1128/JVI.34.2.521-531.1980. View

11.

Rice S, Su L, Knipe D . Herpes simplex virus alpha protein ICP27 possesses separable positive and negative regulatory activities. J Virol. 1989; 63(8):3399-407. PMC: 250915. DOI: 10.1128/JVI.63.8.3399-3407.1989. View

12.

Dobson A, Sederati F, Flanagan W, Farrell M, Stevens J, Wagner E . Identification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J Virol. 1989; 63(9):3844-51. PMC: 250978. DOI: 10.1128/JVI.63.9.3844-3851.1989. View

13.

Frank I, Friedman H . A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J Virol. 1989; 63(11):4479-88. PMC: 251078. DOI: 10.1128/JVI.63.11.4479-4488.1989. View

14.

Stern S, Tanaka M, Herr W . The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16. Nature. 1989; 341(6243):624-30. DOI: 10.1038/341624a0. View

15.

Rock D, Fraser N . Detection of HSV-1 genome in central nervous system of latently infected mice. Nature. 1983; 302(5908):523-5. DOI: 10.1038/302523a0. View

16.

Batterson W, Roizman B . Characterization of the herpes simplex virion-associated factor responsible for the induction of alpha genes. J Virol. 1983; 46(2):371-7. PMC: 255138. DOI: 10.1128/JVI.46.2.371-377.1983. View

17.

Stow N, McMonagle E . Characterization of the TRS/IRS origin of DNA replication of herpes simplex virus type 1. Virology. 1983; 130(2):427-38. DOI: 10.1016/0042-6822(83)90097-1. View

18.

Thompson R, Stevens J . Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent. Virology. 1983; 131(1):171-9. DOI: 10.1016/0042-6822(83)90543-3. View

19.

Quinlan M, Chen L, Knipe D . The intranuclear location of a herpes simplex virus DNA-binding protein is determined by the status of viral DNA replication. Cell. 1984; 36(4):857-68. DOI: 10.1016/0092-8674(84)90035-7. View

20.

Braun D, Batterson W, Roizman B . Identification and genetic mapping of a herpes simplex virus capsid protein that binds DNA. J Virol. 1984; 50(2):645-8. PMC: 255696. DOI: 10.1128/JVI.50.2.645-648.1984. View